Phase III clinical trials

Phase III clinical trials are large-scale studies conducted to confirm a new treatment’s safety and effectiveness. They involve many participants, often hundreds or thousands, and compare the new treatment against existing therapies or a placebo. The goal is to gather enough evidence to show whether the treatment works well and is safe for widespread use. These trials help regulators decide if the treatment should be approved for general use. They are a crucial step in ensuring that new medicines are both effective and safe for the broader population.